<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:hpo ids='HP_0011663'>Arrhythmogenic right ventricular cardiomyopathy</z:hpo> (ARVC) is an uncommon inherited <z:e sem="disease" ids="C0878544" disease_type="Disease or Syndrome" abbrv="">myocardial disorder</z:e> characterised by fibro-fatty <z:mp ids='MP_0001845'>inflammation</z:mp> affecting the right and left ventricles </plain></SENT>
<SENT sid="1" pm="."><plain>It most commonly presents with <z:hpo ids='HP_0001962'>palpitations</z:hpo> or <z:hpo ids='HP_0001279'>syncope</z:hpo> but <z:hpo ids='HP_0001699'>sudden death</z:hpo> may occur, especially in young males </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Diagnosis is not possible with a single test and may be difficult </plain></SENT>
<SENT sid="3" pm="."><plain>Task Force criteria agreed in 1994 comprise major and minor criteria spanning structural abnormalities, ECG appearances, <z:hpo ids='HP_0011675'>arrhythmias</z:hpo>, family history of premature <z:hpo ids='HP_0011420'>death</z:hpo> and myocardial histology </plain></SENT>
<SENT sid="4" pm="."><plain>Modified criteria were introduced in 2010 to improve sensitivity </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: <z:hpo ids='HP_0011663'>Arrhythmogenic right ventricular cardiomyopathy</z:hpo> is a desmosomal disease </plain></SENT>
<SENT sid="6" pm="."><plain>Mutations have been detected in five desmosomal genes, most frequently in plakophilin-2 (PKP2) and multiple mutations are also reported </plain></SENT>
<SENT sid="7" pm="."><plain>Antiarrhythmic drugs such as sotalol and <z:chebi fb="0" ids="2663">amiodarone</z:chebi> may improve symptoms but are unproven to increase survival </plain></SENT>
<SENT sid="8" pm="."><plain>An implantable defibrillator is appropriate in individuals surviving <z:hpo ids='HP_0001695'>cardiac arrest</z:hpo> or sustained <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo>, but there is not yet consensus about prophylactic treatment of Task Force positive but asymptomatic individuals </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: <z:hpo ids='HP_0011663'>Arrhythmogenic right ventricular cardiomyopathy</z:hpo> is more common than previously believed </plain></SENT>
<SENT sid="10" pm="."><plain>Preliminary evidence supports improved sensitivity without loss of specificity using the revised Task Force criteria </plain></SENT>
<SENT sid="11" pm="."><plain>The genetics of the disease are complex but should ultimately advance diagnosis and management </plain></SENT>
</text></document>